Categories Earnings, Health Care
Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance.
- Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last year
- Earnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the year-ago quarter
- On an adjusted basis, Q3 earnings dropped to $5.28 per share from $5.69 per share in the third quarter of 2023
- Operating income for the third quarter was $1.84 billion, compared to $1.86 billion in the year-ago quarter
- The company raised its full-year EPS guidance to the range of $21.35 to $22.07 from the previous guidance of $21.29 to $22.07
- It continues to expect fiscal 2024 revenue to be between $42.4 billion and $43.3 billion
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DRI Earnings: Darden Restaurants’ Q2 2026 sales and profit rise YoY
Darden Restaurants, Inc. (NYSE: DRI), a leading fine dining restaurant chain, on Thursday reported an increase in sales and adjusted earnings for the second quarter of fiscal 2026. Total sales
CarMax (KMX) Q3 2026 earnings drop on lower sales; results beat estimates
Used car retailer CarMax, Inc. (NYSE: KMX) on Thursday reported a decline in earnings for the third quarter of fiscal 2026, hurt by lower sales. However, both revenues and earnings
ACN Earnings: Key quarterly highlights from Accenture’s Q1 2026 financial results
Accenture (NYSE: ACN) reported its first quarter 2026 earnings results today. Revenues of $18.7 billion increased 6% in US dollars and 5% in local currency compared to the same period a